|
 |
NAPRA Drug Schedule
Footnotes:
C1: drug is in the Controlled Drugs and Substances Act and Part I of Part G of the Food and Drugs Act
C2: drug is in the Controlled Drugs and Substances Act and Part II of Part G of the Food and Drugs Act
C3: drug is in the Controlled Drugs and Substances Act and Part III of Part G of the Food and Drugs Act
C4: drug is in the Controlled Drugs and Substances Act
C5: drug is in the Regulations Under CDSA
F1: drug appears in Part I of Schedule F to the Food and Drugs Act
and Regulations
F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR: drug has not been reviewed by NDSAC
R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
TS: drug is in the Annexed Regulations under the Controlled Drugs and Substances Act
U: drug has been reviewed by NDSAC and is unscheduled
"summary": a summary of the recommendation has been developed and
is posted
|
| |
